Starbucks ends employee coverage for these medicines amid rising US health costs Starbucks will cease covering GLP-1 weight-loss drugs for employees starting October. This decision reflects rising costs and a broader employer trend in benefits. GLP-1 drugs, initially for diabetes, are now popular f
Open in BitSocialBitSocial — the social app with no off switch